Trump Strikes Back at Pharma Lobby with Drug Price Executive Order

President Trump's Executive Order Targets Pharmaceutical Lobby: A Press Conference Summary On Monday, May 12th, 2025, President Donald Trump announced a new executive order aimed at lowering prescription drug prices in the United States. The announcement came amidst criticism of the pharmaceutical industry's lobbying efforts against similar initiatives during his previous term. In a press conference, Trump directly addressed the industry, calling it the "most powerful lobby in the world." He stated his intention to investigate companies that don't cooperate with the new policy. "And if necessary, we'll investigate the drug companies and we'll, in particular, investigate the countries that are doing this," Trump said, adding that any additional costs would be added to tariffs. This strong statement reflects the administration's commitment to tackling high drug prices. The executive order is expected to have a significant impact on the pharmaceutical industry and the healthcare system in the US. Further details about the order's specific measures and timeline are expected to be released soon. This action demonstrates a continuing effort by the administration to address rising healthcare costs and ensure fair pricing for American consumers.